Chapter 14 Interactions between the Membrane-Cytoskeleton and CD44 during Lymphocyte Signal Transduction and Cell Adhesion

[1]  H. Liao,et al.  N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding. , 1995, Journal of immunology.

[2]  L. Bourguignon,et al.  Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells , 1995, Journal of cellular physiology.

[3]  A. Perschl,et al.  Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation , 1995, The Journal of experimental medicine.

[4]  K. Oritani,et al.  Glycosylation of CD44 negatively regulates its recognition of hyaluronan , 1995, The Journal of experimental medicine.

[5]  L. Bourguignon,et al.  Ryanodine Receptor-Ankyrin Interaction Regulates Internal Ca Release in Mouse T-lymphoma Cells (*) , 1995, The Journal of Biological Chemistry.

[6]  C. Isacke,et al.  Hyaluronan binding by CD44 is regulated by a phosphorylation‐independent mechanism , 1995, European journal of immunology.

[7]  S. Jalkanen,et al.  CD44v6 expression in non‐Hodgkin's lymphoma: An association with low histological grade and poor prognosis , 1995, The Journal of pathology.

[8]  G. Dougherty,et al.  To metastasize or not? Selection of CD44 splice sites , 1995, Nature Medicine.

[9]  A. Droll,et al.  Adhesive interactions between alternatively spliced CD44 isoforms , 1995, Journal of Biological Chemistry.

[10]  L. Bourguignon,et al.  Identification of the Ankyrin-binding Domain of the Mouse T-lymphoma Cell Inositol 1,4,5-Trisphosphate (IP3) Receptor and Its Role in the Regulation of IP3-mediated Internal Ca2+ Release (*) , 1995, The Journal of Biological Chemistry.

[11]  H. Sorimachi,et al.  A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan , 1995, The Journal of Biological Chemistry.

[12]  S. Kumar,et al.  The role of hyaluronan in tumour neovascularization (review) , 1995, International journal of cancer.

[13]  V. Bennett,et al.  AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier. , 1995, The Journal of biological chemistry.

[14]  J. Bell,et al.  Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon , 1995, The Journal of cell biology.

[15]  I. Stamenkovic,et al.  CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor , 1995, The Journal of cell biology.

[16]  I. Trowbridge,et al.  Role of CD44 cytoplasmic domain in hyaluronan binding , 1995, European journal of immunology.

[17]  E. Puré,et al.  Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain , 1995, The Journal of experimental medicine.

[18]  L. Bourguignon,et al.  New CD44 splice variants associated with human breast cancers , 1995, Journal of cellular physiology.

[19]  C. Isacke,et al.  The role of the cytoplasmic domain in regulating CD44 function. , 1994, Journal of cell science.

[20]  L. Bourguignon,et al.  Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function , 1994, The Journal of cell biology.

[21]  N. Sato,et al.  ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons , 1994, The Journal of cell biology.

[22]  R. Savani,et al.  Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. , 1994, The EMBO journal.

[23]  X. Chen,et al.  Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. , 1993, Journal of immunology.

[24]  H. Liao,et al.  Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. , 1993, Journal of immunology.

[25]  P. Herrlich,et al.  CD44 splice variants: metastases meet lymphocytes. , 1993, Immunology today.

[26]  I. Stamenkovic,et al.  Identification of hyaluronic acid binding sites in the extracellular domain of CD44 , 1993, The Journal of cell biology.

[27]  L. Bourguignon,et al.  The involvement of ankyrin in the regulation of inositol 1,4,5-trisphosphate receptor-mediated internal Ca2+ release from Ca2+ storage vesicles in mouse T-lymphoma cells. , 1993, The Journal of biological chemistry.

[28]  P. Herrlich,et al.  Splicing choice from ten variant exons establishes CD44 variability. , 1993, Nucleic acids research.

[29]  P. Herrlich,et al.  A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps , 1993, The Journal of cell biology.

[30]  J. Bell,et al.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Ishihara,et al.  Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition , 1992, The Journal of cell biology.

[32]  L. Bourguignon,et al.  The lymphoma transmembrane glycoprotein GP85 (CD44) is a novel guanine nucleotide-binding protein which regulates GP85 (CD44)-ankyrin interaction. , 1992, The Journal of biological chemistry.

[33]  D. Tarin,et al.  Significance of CD44 gene products for cancer diagnosis and disease evaluation , 1992, The Lancet.

[34]  Y. Nishizuka.  Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.

[35]  L. Bourguignon,et al.  A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin , 1992, Molecular and cellular biology.

[36]  P. Herrlich,et al.  Participation in normal immune responses of a metastasis-inducing splice variant of CD44. , 1992, Science.

[37]  V. Bennett,et al.  Ankyrins. Adaptors between diverse plasma membrane proteins and the cytoplasm. , 1992, The Journal of biological chemistry.

[38]  S. Jalkanen,et al.  Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin , 1992, The Journal of cell biology.

[39]  Q. He,et al.  Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody , 1992, The Journal of experimental medicine.

[40]  P. Herrlich,et al.  CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. , 1991, Cancer research.

[41]  L. Bourguignon,et al.  Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. , 1991, The Journal of biological chemistry.

[42]  V. Bennett,et al.  Distinct ankyrin isoforms at neuron cell bodies and nodes of Ranvier resolved using erythrocyte ankyrin-deficient mice , 1991, The Journal of cell biology.

[43]  D. Benos,et al.  Amiloride-sensitive sodium channel is linked to the cytoskeleton in renal epithelial cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  L. Bourguignon,et al.  Acylation of the lymphoma transmembrane glycoprotein, GP85, may be required for GP85-ankyrin interaction. , 1991, The Journal of biological chemistry.

[45]  S. Jalkanen,et al.  Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. , 1991, The Journal of clinical investigation.

[46]  Martin Hofmann,et al.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.

[47]  E. Turley,et al.  Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells , 1991, The Journal of cell biology.

[48]  M. Amiot,et al.  The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells. , 1991, The EMBO journal.

[49]  Frank McCormick,et al.  The GTPase superfamily: conserved structure and molecular mechanism , 1991, Nature.

[50]  M. Letarte,et al.  Confirmation by peptide sequence and co-expression on various cell types of the identity of CD44 and P85 glycoprotein. , 1990, Molecular immunology.

[51]  C. Meijer,et al.  Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). , 1990, Leukemia.

[52]  K. Miyake,et al.  Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition , 1990, The Journal of experimental medicine.

[53]  R. Schulte,et al.  Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. , 1990, Experimental cell research.

[54]  J. August,et al.  Homotypic cell aggregation induced by anti-CD44(Pgp-1) monoclonal antibodies and related to CD44(Pgp-1) expression. , 1990, Journal of immunology.

[55]  T. Hamaoka,et al.  Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long- term bone marrow cultures , 1990, The Journal of experimental medicine.

[56]  M. Schmidt.  Fatty acylation of proteins , 1989, Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes.

[57]  M. Telen,et al.  CD44--a molecule involved in leukocyte adherence and T-cell activation. , 1989, Immunology today.

[58]  D. Goeddel,et al.  Molecular cloning and expression of Pgp-1. The mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor. , 1989, Journal of immunology.

[59]  J. Lingrel,et al.  Characterization of the human Na,K-ATPase alpha 2 gene and identification of intragenic restriction fragment length polymorphisms. , 1989, The Journal of biological chemistry.

[60]  S. Kumar,et al.  The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. , 1989, Experimental cell research.

[61]  V. Bennett,et al.  Mapping the ankyrin-binding site of the human erythrocyte anion exchanger. , 1989, The Journal of biological chemistry.

[62]  L. Bourguignon,et al.  Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-ankyrin binding. , 1989, The Journal of biological chemistry.

[63]  L. Picker,et al.  A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins , 1989, Cell.

[64]  M. Kashgarian,et al.  Ankyrin links fodrin to the alpha subunit of Na,K-ATPase in Madin-Darby canine kidney cells and in intact renal tubule cells , 1989, The Journal of cell biology.

[65]  G. Tarone,et al.  Aggregation of macrophages and fibroblasts is inhibited by a monoclonal antibody to the hyaluronate receptor. , 1988, Experimental cell research.

[66]  S. Jalkanen,et al.  Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. , 1988, Journal of immunology.

[67]  William,et al.  Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. , 1988, The Journal of biological chemistry.

[68]  L. Bourguignon,et al.  Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin , 1988, The Journal of cell biology.

[69]  P. Comoglio,et al.  The hyaluronate receptor is identical to a glycoprotein of Mr 85,000 (gp85) as shown by a monoclonal antibody that interferes with binding activity. , 1987, The Journal of biological chemistry.

[70]  Nelson Wj,et al.  Ankyrin binding to (Na+ + K+)ATPase and implications for the organization of membrane domains in polarized cells. , 1987 .

[71]  J. R. de los Toyos,et al.  Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells , 1987, The Journal of cell biology.

[72]  L. Bourguignon,et al.  A lymphoma plasma membrane-associated protein with ankyrin-like properties , 1986, The Journal of cell biology.

[73]  B. E. Lacy,et al.  Characterization and identification of the hyaluronate binding site from membranes of SV-3T3 cells. , 1985, The Journal of biological chemistry.

[74]  R. Schulte,et al.  Evidence that the Pgp-1 glycoprotein is expressed on thymus-homing progenitor cells of the thymus. , 1985, Cellular immunology.

[75]  C. Underhill.  Interaction of hyaluronate with the surface of simian virus 40-transformed 3T3 cells: aggregation and binding studies. , 1982, Journal of cell science.

[76]  J. Woodruff,et al.  Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules , 1976, The Journal of experimental medicine.

[77]  I. Roitt,et al.  Encyclopedia of immunology , 1998 .

[78]  A. Miyawaki,et al.  Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. , 1994, Receptors & channels.

[79]  K. Miyake,et al.  A new cell adhesion mechanism involving hyaluronate and CD44. , 1990, Current topics in microbiology and immunology.

[80]  M. Letarte,et al.  A glycoprotein of molecular weight 85,000 on human cells of B-lineage: detection with a family of monoclonal antibodies. , 1985, Molecular immunology.